Safety and Preliminary Efficacy Study of GX-I7 in Patients With COVID-19

Summary

This study is a phase 1b clinical trial to investigate the safety and preliminary effects of a single dose of a test drug or placebo to the subjects who has diagnosed as COVID-19 infection.

Timeline

Start

2021-03-24

Primary completion

2022-05-08

Completion

2022-07-07

Drugs

Indications